Modified helicases
AssigneeOxford Nanopore Technologies PLC
InventorsAndrew John Heron, James Anthony Clarke, Ruth Moysey, Elizabeth Jayne Wallace, Mark John Bruce, Lakmal Jayasinghe, Domenico Caprotti, Szabolcs Soeroes, Luke McNeill, David Antoni Alves, Rebecca Victoria Bowen, John Milton
Life of this patent
Estimating the term…
Abstract
The invention relates to modified helicases with reduced unbinding from polynucleotides. The helicases can be used to control the movement of polynucleotides and are particularly useful for sequencing polynucleotides.
Claims13
A kit for characterising a target polynucleotide comprising (a) a pore and (b) a helicase comprising a polynucleotide binding domain, wherein two amino acid residues that are located on a surface of the helicase are covalently connected via a linkage between the two amino acid residues to form a covalently-closed structure, wherein the pore is a transmembrane pore, wherein the transmembrane pore is:
- [i] derived from a hemolysin, leukocidin, Mycobacterium smegmatis porin A (MspA), MspB, MspC, MspD, outer membrane porin F (OmpF), outer membrane porin G (OmpG), outer membrane phospholipase A, Neisseria autotransporter lipoprotein (NalP) and WZA, or
- [ii] a β-barrel pore or an α-helix bundle pore, wherein at least one amino acid of the two amino acid residues is substituted with cysteine, a non-natural amino acid or 4-azido-L-phenylalanine (Faz), and wherein the two amino acid residues that are located on the surface of the helicase are on one or more loop regions connecting α-helices and β-strands of the helicase and/or are spatially located proximal to the polynucleotide binding domain.
Dependencies are inferred from the claim text.